Southpoint Capital Advisors LP - 18 Nov 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: 10%+ Owner
Signature: s/ John S. Clark II, Southpoint Capital Advisors LP, by Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
Issuer symbol: FENC
Transactions as of: 18 Nov 2025
Net transactions value: -$170,048
Form type: 4
Filing time: 20 Nov 2025, 16:07:55 UTC
Previous filing: 17 Nov 2025
Next filing: 29 Dec 2025
SEC: View on sec.gov

Reporting Owners (5)

Name	Relationship	Address	Signature	Signature date	CIK
Southpoint Capital Advisors LP	10%+ Owner	1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK	s/ John S. Clark II, Southpoint Capital Advisors LP, by Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member	20 Nov 2025	0001319998
Southpoint Capital Advisors LLC	10%+ Owner	1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK	/s/ John S. Clark II, Southpoint Capital Advisors LLC, by John S. Clark II, Managing Member	20 Nov 2025	0001378377
Southpoint GP, LP	10%+ Owner	1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK	/s/ John S. Clark II, Southpoint GP, LP, by Southpoint GP, LLC, its General Partner, by John S. Clark II, Managing Member	20 Nov 2025	0001378376
Southpoint GP, LLC	10%+ Owner	1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK	/s/ John S. Clark II, Southpoint GP, LLC, by John S. Clark II, Managing Member	20 Nov 2025	0001378378
Clark John Smith II	10%+ Owner	1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK	/s/ John S. Clark II	20 Nov 2025	0001378379

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FENC	Common Stock	Sale	$170,048	-19,341	-0.51%	$8.79	3,744,741	18 Nov 2025	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
F2	The transaction was executed in multiple trades at prices ranging from $8.75 to $8.845. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.

Content

The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.

The transaction was executed in multiple trades at prices ranging from $8.75 to $8.845. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.